Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anjan Drug is a specialized Active Pharmaceutical Ingredient (API) manufacturer based in Chennai, India, with a core focus on the Central Nervous System (CNS) therapeutic area. Established in 1990, the company has grown into one of the world's largest producers of Valproic Acid and its derivatives, such as Sodium Valproate and Divalproex Sodium. Its manufacturing facilities are compliant with international standards, holding certifications from the USFDA, EDQM, and WHO-GMP. In 2020, Anjan Drug was acquired by Solara Active Pharma Sciences, integrating its niche CNS portfolio into Solara's broader API platform. The company continues to serve a global clientele, providing high-quality chemical synthesis and large-scale API production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anjan Drugs.